Department of Licensing and Regulatory Affairs
Bureau of Professional Licensing
NOTICE OF PUBLIC HEARING
October 4, 2019
9:00 a.m.
Location: G. Mennen Williams Building Auditorium
525 W. Ottawa Street, Lansing, Michigan
The hearing is held to receive public comments on the following administrative rules:
Board of Pharmacy – General Rules (ORR #2018-039 LR)
Authority: MCL 333.16145; MCL 333.16148; MCL 333.16174; MCL 333.16175; MCL 333.16178;
MCL 333.16182; MCL 333.16186; MCL 333.17722; MCL 333.17731; MCL 333.17737; MCL
333.17746; MCL 333.17748; MCL 333.17748a; MCL 333.17748b; MCL 333.17751; MCL 333.17753;
MCL 333.17757; MCL 333.17760; MCL 333.17767; MCL 338.3501; MCL 445.2001; MCL 445.2011;
and MCL 445.2030.
Overview: The current Pharmacy – General Rules will be substantially rewritten and reorganized to
provide for rules that encompass all the necessary requirements for licensing and regulating the practice
for pharmacists, interns, preceptors, pharmacies, manufacturers, and wholesale distributors. The proposed
revisions modify the parts pertaining to general provisions, pharmacist licenses, pharmacy licenses,
manufacturer licenses, wholesale distributor licenses, and the practice of pharmacy.
Board of Pharmacy – Pharmacist Continuing Education (ORR #2019-022 LR)
Authority: MCL 333.16145; MCL 333.16148; MCL 333.16184; MCL 333.16201; MCL 333.16204;
MCL 333.16205; MCL 333.17731; MCL 333.17737; MCL 333.17767; MCL 338.3501; MCL 445.2001;
MCL 445.2011; and MCL 445.2030.
Overview: The proposed changes will: require completion of training for identifying victims of human
trafficking and training in opioids and other controlled substances awareness before renewal of the license;
clarify that continuing education (CE) is only required if a licensee has been licensed for a full 2-year license
cycle; require 1 hour of CE in pharmacy ethics and jurisprudence; clarify the pain and symptom management
requirement; limit CE credit for taking the same CE course or program twice during 1 renewal period;
require documentation of meeting CE requirements; require a waiver request prior to the expiration date of
the license; modify CE approval standards; organize CE activities in a table; add CE activities for credit;
require specific proof for CE; and rescind the CE rule regarding renewal requirements for a pharmacist who
resides or practices in another state.
The rules will take effect immediately upon filing with the Secretary of State, unless specified otherwise in the
rules. Comments on the proposed rules may be presented in person at the public hearing. Written comments
will also be accepted from date of publication until 5:00 p.m. on October 4, 2019, at the following address or
e-mail address:
Department of Licensing and Regulatory Affairs
Bureau of Professional Licensing– Boards and Committees Section
P.O. Box 30670